retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial The TRIUMPH-1 3 results just dropped on retatrutide. Here is what the numbers actually say. is a agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Beyond GLP-1: Retatrutide's triple-agonist mechanism
Pay in 4 interest-free payments of $5.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
















.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
:max_bytes(150000):strip_icc()/Health-GettyImages-2148794370-35f2862b1a4e47a888cd8d9c3e81fe28.jpg)







